| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |